139 related articles for article (PubMed ID: 28849773)
1. Double Dose Versus Standard Dose Hepatitis B Vaccine in HIV-infected Children: A Randomized Controlled Trial.
Siddiqui SA; Maurya M; Singh DK; Srivastava A; Rai R
Indian Pediatr; 2017 Dec; 54(12):1017-1020. PubMed ID: 28849773
[TBL] [Abstract][Full Text] [Related]
2. Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial.
Rey D; Piroth L; Wendling MJ; Miailhes P; Michel ML; Dufour C; Haour G; Sogni P; Rohel A; Ajana F; Billaud E; Molina JM; Launay O; Carrat F;
Lancet Infect Dis; 2015 Nov; 15(11):1283-91. PubMed ID: 26257021
[TBL] [Abstract][Full Text] [Related]
3. Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial.
Launay O; van der Vliet D; Rosenberg AR; Michel ML; Piroth L; Rey D; Colin de Verdière N; Slama L; Martin K; Lortholary O; Carrat F;
JAMA; 2011 Apr; 305(14):1432-40. PubMed ID: 21486976
[TBL] [Abstract][Full Text] [Related]
4. Persistence of Hepatitis B Immunity Following 3-dose Infant Primary Series in HIV-infected Thai Adolescents and Immunologic Response to Revaccination.
Lapphra K; Angkhananukit P; Saihongthong S; Phongsamart W; Wittawatmongkol O; Rungmaitree S; Chokephaibulkit K
Pediatr Infect Dis J; 2017 Sep; 36(9):863-868. PubMed ID: 28419007
[TBL] [Abstract][Full Text] [Related]
5. Higher rate of long-term serologic response of four double doses vs. standard doses of hepatitis B vaccination in HIV-infected adults: 4-year follow-up of a randomised controlled trial.
Chaiwarith R; Praparattanapan J; Kotarathititum W; Wipasa J; Chaiklang K; Supparatpinyo K
AIDS Res Ther; 2019 Nov; 16(1):33. PubMed ID: 31711528
[TBL] [Abstract][Full Text] [Related]
6. Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults.
Potsch DV; Camacho LA; Tuboi S; Villar LM; Miguel JC; Ginuíno C; Silva EF; Mendonça RM; Moreira RB; Barroso PF
Vaccine; 2012 Sep; 30(41):5973-7. PubMed ID: 22828589
[TBL] [Abstract][Full Text] [Related]
7. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I
HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875
[TBL] [Abstract][Full Text] [Related]
8. Serological response to hepatitis B virus vaccine in HIV-infected children in Tanzania.
Pippi F; Bracciale L; Stolzuoli L; Giaccherini R; Montomoli E; Gentile C; Filetti S; De Luca A; Cellesi C
HIV Med; 2008 Aug; 9(7):519-25. PubMed ID: 18554311
[TBL] [Abstract][Full Text] [Related]
9. Immune Response to Double Dose Hepatitis-B Vaccine using Four Dose Schedule in HIV Infected Children.
Bose D; Chandra J; Dutta R; Jais M; Ray S; Gupta RA; Seth A; Kumar P
Indian J Pediatr; 2016 Aug; 83(8):772-6. PubMed ID: 26786256
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of protective level of hepatitis B antibody 3 years after revaccination in HIV-infected children on antiretroviral therapy.
Lao-Araya M; Puthanakit T; Aurpibul L; Taecharoenkul S; Sirisanthana T; Sirisanthana V
Vaccine; 2011 May; 29(23):3977-81. PubMed ID: 21473954
[TBL] [Abstract][Full Text] [Related]
11. Randomized study of intradermal compared to intramuscular hepatitis B vaccination in HIV-infected children without severe immunosuppression.
Bunupuradah T; Ananworanich J; Pancharoen C; Petoumenos K; Prasitsuebsai W; Wongngam W; Ubolyam S; Sriheara C; Lange J; Phanuphak P; Puthanakit T
Vaccine; 2011 Apr; 29(16):2962-7. PubMed ID: 21329776
[TBL] [Abstract][Full Text] [Related]
12. Antibody response to hepatitis B immunization in infants born to HIV-infected mothers.
Thaithumyanon P; Punnahitananda S; Praisuwanna P; Thisyakorn U; Ruxrungtham K
J Med Assoc Thai; 2002 Mar; 85(3):277-82. PubMed ID: 12117014
[TBL] [Abstract][Full Text] [Related]
13. High rates of serological response to a modified hepatitis B vaccination schedule in HIV-infected adults subjects.
Potsch DV; Oliveira ML; Ginuíno C; Miguel JC; Oliveira SA; Silva EF; Moreira RB; Cruz GV; Oliveira AL; Camacho LA; Barroso PF
Vaccine; 2010 Feb; 28(6):1447-50. PubMed ID: 19995540
[TBL] [Abstract][Full Text] [Related]
14. Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose.
Fonseca MO; Pang LW; de Paula Cavalheiro N; Barone AA; Heloisa Lopes M
Vaccine; 2005 Apr; 23(22):2902-8. PubMed ID: 15780739
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the HBV vaccine response in a group of HIV-infected children in Morocco.
Haban H; Benchekroun S; Sadeq M; Benjouad A; Amzazi S; Oumzil H; Elharti E
BMC Public Health; 2017 Sep; 17(1):752. PubMed ID: 28962610
[TBL] [Abstract][Full Text] [Related]
16. [Hepatitis B vaccination effectiveness based on anti-HBs antibodies presence in children vertically infected with HIV].
Ołdakowska A; Marczyńska M
Przegl Epidemiol; 2010; 64(2):323-8. PubMed ID: 20731246
[TBL] [Abstract][Full Text] [Related]
17. Immune memory and immune response in children from Bulgaria 5-15 years after primary hepatitis B vaccination.
Teoharov P; Kevorkyan A; Petrova N; Baltadzhiev I; Van Damme P
Pediatr Infect Dis J; 2013 Jan; 32(1):51-3. PubMed ID: 22914584
[TBL] [Abstract][Full Text] [Related]
18. Assessing the immunological response to hepatitis B vaccination in HIV-infected patients in clinical practice.
Mena G; Llupià A; García-Basteiro AL; Díez C; León A; García F; Bayas JM
Vaccine; 2012 May; 30(24):3703-9. PubMed ID: 22446635
[TBL] [Abstract][Full Text] [Related]
19. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates.
Jafarzadeh A; Zarei S; Shokri F
Vaccine; 2008 Jan; 26(2):269-76. PubMed ID: 18037544
[TBL] [Abstract][Full Text] [Related]
20. Long-term Immune Response to Hepatitis B Virus Vaccination Regimens in Adults With Human Immunodeficiency Virus 1: Secondary Analysis of a Randomized Clinical Trial.
Launay O; Rosenberg AR; Rey D; Pouget N; Michel ML; Reynes J; Neau D; Raffi F; Piroth L; Carrat F;
JAMA Intern Med; 2016 May; 176(5):603-10. PubMed ID: 27064975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]